Teva Pharmaceutical Industries Ltd. has announced the launch of a generic version of Tracleer® (bosentan) tablets, 6...
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep fa...
GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the pre...
Mayne Pharma Group Limited has announced that the US Food and Drug Administration (FDA) has approved SORILUX® (...
Sandoz has announced that it has received regulatory approval from China's National Medical Products Administration (NMP...
Alembic has entered into a Joint Venture Agreement ('JVA') with SPH SINE Pharmaceutical Laboratories Co Ltd, China ('SPH...
CStone Pharmaceuticals and Numab Therapeutics AG have entered into an exclusive regional licensing agreement for the dev...
EirGenix, Inc. has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, gran...
Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of AndroGel ®i (testosterone...
Teva Pharmaceutical has announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Su...
Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...
Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a S...
Regeneron Pharmaceuticals and Sanofi recently announced that the European Medicines Agency's Committee fo...
Pharma major Lupin announced that it has received approval for its Azacitidine for Injection, 100 mg Single-Dose Vial fr...
Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treat...
Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United State...
Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States ...
India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdo...
